BPCIA Litigation - Lessons from the Trenches

Reference Materials

Biosimilar Litigation Activity In 2019 (5 Pages)
Amgen Inc., Amgen Manufacturing ltd. v. Cherus Biosciences (12 Pages)
Amgen Inc., Amgen Manufacturing ltd. v. Hospira, Inc. (24 Pages)
Amgen Inc., Amgen Manufacturing, ltd. v. Sandoz Inc., Sandoz International GMBH, Sandoz GMBH (16 Pages)
Genentech, Inc., City of Hope v. Amgen Inc. (2 Pages)
Genentech, Inc., City of Hope v. Immunex Rhode Island Corporation, Amgen Inc., District of Delaware (18 Pages)
Genentech, Inc., City of Hope v. Immunex Rhode Island Corporation, Amgen Inc., Federal Circuit (2 Pages)
Immunex Corporation, Amgen Manufacturing, ltd., Hoffmann-La Roche Inc. v. Sandoz Inc., Sandoz International GMBH, Sandoz GMBH (4 Pages)
Janssen Biotech, Inc. v. Celltrion Healthcare Co., ltd., et al. (104 Pages)

Join Patent Litigation and Women in IP committees for a discussion about the unique issues and challenges that arise in BPCIA litigation, from the perspective of in-house and outside counsel who have litigated the cases.  

Panelists
Karen Shen, Senior Corporate Counsel, Pfizer
Heather M. Schneider, Partner, Willkie Farr & Gallagher
Irena Royzman, Ph.D., Partner, Kramer Levin

Moderator
Katherine A. (“Kassie”) Helm, Ph.D., Partner, Dechert 

Schedule
6:00 PM - 6:30 PM Registration
6:30 PM - 7:30 PM Presentation
7:30 PM - 8:00 PM Reception

EARN 1.0 PROFESSIONAL CLE CREDIT

Hosted by the NYIPLA Patent Litigation and Women in IP committees

Sponsored by

Sponsorship Opportunities

NYIPLA reaches a diverse community of intellectual property professionals through a wide range of programs and activities that can provide a rewarding sponsorship experience. Benefits include: sponsor recognition, logo displays, promotional materials, and more. Click HERE for Sponsorship details.